Hot Investor Mandate: Global Investment Firm Invests Up to $40M in Early Clinical Stage Therapeutics, Medical Devices, and Diagnostics Companies

5 Jan

A global investment firm with bases in USA and Asia is primarily focused on healthcare investments and looks to make allocations ranging from $1M to $40M depending on opportunity and risk/reward. The firm is actively seeking new investments and is open to review opportunities from around the globe.

Within the life science space the firm is interested in Therapeutics, Medical Devices, and Diagnostics. The firm is currently most interested in companies with some clinical data however they are open to reviewing pre-clinical stage opportunities as well. The firm is open to biosimilar and repurposed assets, and has a preference for platform technologies but is also open to considering single asset opportunities. The firm is open to review all classes of medical devices and diagnostics. The firm is entirely open in terms of indication.

The firm is open to investing in both private and publicly held companies and is currently very interested in making cross over investments. The firm is also very interested in companies that have a plan or ability to enter the Chinese market as the firm can add significant value with this strategy. The firm is open to acting as both a lead and co-investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: